Jenburkt Pharmaceuticals Ltd

JENBURPH
Health CarePharmaceuticals
SmallcapWith a market cap of ₹255 cr, stock is ranked 1,586
Moderate RiskStock is 2.24x as volatile as Nifty
564.958.10 (+1.45%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹255 cr, stock is ranked 1,586
Moderate RiskStock is 2.24x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
15.48
PB RatioPB Ratio
2.60
Dividend YieldDiv. Yield
1.83%
Sector PESector PE
33.53
Sector PBSector PB
4.83
Sector Div YldSctr Div Yld
0.83%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jenburkt Pharmaceuticals Limited is engaged in the manufacture of pharmaceutical formulations. The Company offers prescription and over-the-counter drugs.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021118.06126.05123.11113.6017.2119.7914.8716.51
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnApr 18, 2022

JENBURKT PHARMACEUTICALS LTD. - 524731 - Certificate U/R 40(10) Of SEBI (LODR) Regulations, 2015 For The Financial Year Ended On 31.03.2022.. | Download

JENBURKT PHARMACEUTICALS LTD. - 524731 - Certificate U/R 40(10) Of SEBI (LODR) Regulations, 2015 For The Financial Year Ended On 31.03.2022.. | Download

Cash Dividend 
Ex. DateAug 30, 2021

Final • Div/Share: ₹ 10.2

Cash Dividend 
Ex. DateMar 18, 2020

Interim • Div/Share: ₹ 8.1

See all events